Improved sexual function during recombinant human erythropoietin therapy

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
J BommerR Seelig

Abstract

In seven male haemodialysis patients, living with a constant sexual partner, sexual life (self-administered questionnaire) and sex hormones were evaluated before and 3 or 10 months after commencement of recombinant human erythropoietin (rHuEpo) therapy respectively. Haematocrit increased from 22.2 +/- 2.1% to 30.6 +/- 1% with a maintenance dose of 140 +/- 55 U/kg per week. Two patients were hypertensive before and after rHuEpo therapy; antihypertensive medication was kept constant during the study. Self-reported sexual function improved in four of seven patients, including libido and erection. This was paralleled by improved indices of wellbeing (physical fitness, mental alertness). In contrast, serum values of sexual hormones (testosterone or oestradiol) and of basal and stimulated (LHRH/TRH), prolactin and LH, and FSH were not significantly changed during rHuEpo therapy.

Citations

Apr 6, 2004·Molecular and Cellular Endocrinology·Takafumi YamazakiMasato Fujisawa
Feb 24, 2006·Journal of Sports Sciences·Grégory NinotCorrine Caillaud
Nov 8, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Todd F GriffithWilliam F Owen
Jun 26, 2007·American Journal of Nephrology·Markus RiegerspergerGere Sunder-Plassmann
Aug 1, 1995·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·N MuirheadP Parfrey
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Eduardo LacsonJ Michael Lazarus
Sep 26, 2009·Transplant International : Official Journal of the European Society for Organ Transplantation·Hamoud H Al Khallaf
Oct 12, 2005·The Journal of Urology·Mohamad E AllafArthur L Burnett
Jun 26, 2001·Clinical and Laboratory Haematology·D S SilverbergM Blum
Aug 5, 2008·The Journal of Bone and Joint Surgery. American Volume·John C ElfarMichael J Zuscik
Feb 28, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alice SchmidtWalter H Hörl
Nov 7, 2008·Nephrology·Lawrence McMahon, UNKNOWN Caring for Australians with Renal Impairment (CARI)
Feb 1, 1991·Scottish Medical Journal·W K Stewart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.